Related posts
Most Anticipated Earnings: MRE-T, PSI-T and more Canadian Companies Reporting Earnings this Week (Aug 05-09).Most Anticipated Earnings: BLDP-T, BOS-T and more Canadian Companies Reporting Earnings this Week (May 06-10)Most Anticipated Earnings: SLF-T, REAL-T and more Canadian Companies Reporting Earnings this Week (Nov 13-17)This summary was created by AI, based on 1 opinions in the last 12 months.
Experts believe that dentalcorp Holdings is well run with stable and predictable business operations. They expect the company to be acquired by a big US player in the future, as they have been diligent in not overpaying for acquisitions. However, the experts also note that the company's leverage is too elevated for their liking, and they do not anticipate any major transformational news. Overall, they see potential for margins to increase gradually over time, but acknowledge the challenge of acquiring as many practices as they would like.
Not a good performing company from a technical perspective.
Largest and fastest growing network of dental practices.
Current share price a good price for long term investors.
Dentistry business not going anywhere.
dentalcorp Holdings is a Canadian stock, trading under the symbol DNTL-T on the Toronto Stock Exchange (DNTL-CT). It is usually referred to as TSX:DNTL or DNTL-T
In the last year, 1 stock analyst published opinions about DNTL-T. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for dentalcorp Holdings.
dentalcorp Holdings was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for dentalcorp Holdings.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of dentalcorp Holdings published on Stockchase.
On 2025-01-14, dentalcorp Holdings (DNTL-T) stock closed at a price of $7.87.
Over time, expects it to be acquired by a big US player. Has been quite diligent not overpaying for acquisitions. Difficult to buy as many practices as they'd like. Pretty well run. Margins can increase step by step over time. Doesn't expect any big transformational news. Leverage is too elevated for his liking. Stable, predictable business.